CKD

BOSTON, Mass. | June 23, 2026 Mediar Therapeutics has announced that the first cohorts have been dosed in its...

ALLSCHWIL, Switzerland, June 1, 2026 Idorsia Ltd announced new Phase 3 PRECISION study analyses showing that aprocitentan, its dual...

TORONTO, May 22, 2026 Arch Biopartners announced that Royal Columbian Hospital (RCH) in British Columbia has dosed its first...

Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...

Tokyo, Japan, November 26 2025 — Renalys Pharma has announced positive topline results from its Phase III clinical study...

SLondon, UK – October 7, 2025 – AstraZeneca announced that Baxdrostat met the primary endpoint in the Bax24 Phase...